- **Vireo Growth Inc.** (VREOF) has entered into definitive agreements, effective **October 2, 2025**, to acquire approximately **86%** of the outstanding **13% Senior Secured Convertible Notes** of Medicine Man Technologies Inc. (dba Schwazze).  **[1771706_0001104659-25-097924_tm2528251d1_ex10-1.htm:0]** **[1771706_0001104659-25-097924_tm2528251d1_ex10-2.htm:0]** **[1771706_0001104659-25-097924_tm2528251d1_ex99-1.htm:0]** **[1771706_0001104659-25-097924_tm2528251d1_8k.htm:1]** 
- The notes, which have a value of approximately **$91,000,000** (consisting of principal and accrued interest), are being acquired for total consideration of approximately **$62,000,000**.  **[1771706_0001104659-25-097924_tm2528251d1_ex99-1.htm:0]** **[1771706_0001104659-25-097924_tm2528251d1_8k.htm:1]** 
- The consideration will be paid in **Vireo's subordinate voting shares** at a deemed price of **$0.54 per share**.  **[1771706_0001104659-25-097924_tm2528251d1_ex99-1.htm:0]** **[1771706_0001104659-25-097924_tm2528251d1_8k.htm:1]** 
- Schwazze is currently in **default on its payment obligations** under these notes.  **[1771706_0001104659-25-097924_tm2528251d1_8k.htm:1]** 
- The transaction is expected to close by **October 31, 2025**, subject to customary conditions, including Canadian Stock Exchange approval.  **[1771706_0001104659-25-097924_tm2528251d1_ex99-1.htm:0]** **[1771706_0001104659-25-097924_tm2528251d1_8k.htm:1]**

Vireo Growth (VREOF)